skip to content
Systematic Reviews of Treatments for Hepatitis B
Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of treatments for Hepatitis B.
Reviewed December 2011
13 Resources Found
Results 1 to 13 displayed.
| Title: | Hepatitis B vaccination during pregnancy for preventing infant infection |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Hepatitis B is an infection caused by the hepatitis B virus and occurs worldwide. For infants and children, the two main sources of the infection are transmission from an infected mother or living in an infected household. Perinatal transmission is comm... |
| Date: | Jan 2011 |
| Title: | Phyllanthus species for chronic hepatitis B virus infection |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Chronic hepatitis B virus (HBV) infection causes significant mortality, morbidity, and economic burden worldwide. Although the current approved therapies are effective, response to treatment is not satisfactory. Patients are at high risk of developing v... |
| Date: | Oct 2010 |
| Title: | Booster dose vaccination for preventing hepatitis B |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Antibodies against hepatitis B surface antigen (anti-HBs) wane over time after vaccination for hepatitis B, hence the duration of protection provided by HB vaccine is still unknown. However, the presence of immune memory can be evaluated indirectly by m... |
| Date: | Jul 2010 |
| Title: | Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Chronic hepatitis B is a very common infectious disease leading to chronic liver disease, affecting around 350 million people all over the world. Liver transplantation is often the only viable treatment option. Recurrence of hepatitis B virus (HBV) infe... |
| Date: | Apr 2009 |
| Title: | Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB) |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Childhood vaccinations provide an effective method of protection against many diseases. There are multiple advantages to combining vaccines: reducing the number of visits, injections and patient discomfort, increasing compliance, and optimizing preventi... |
| Date: | Mar 2009 |
| Title: | Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Several million people world-wide are infected with hepatitis B virus. The infection may cause serious short-term and long-term effects including portal hypertension, liver failure, liver cancer, and death. Hepatitis B vaccination is reported to be bene... |
| Date: | May 2008 |
| Title: | Bicyclol for chronic hepatitis B |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Bicyclol is a novel synthetic 'anti-hepatitis' drug, used primarily in China for patients with chronic hepatitis B. No well-designed randomised clinical trials were found evaluating the benefits or possible harms of bicyclol for patients with chronic he... |
| Date: | Aug 2006 |
| Title: | Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Interferon is an established treatment for chronic infection with hepatitis B virus. Although it is effective, response rates are not satisfactory. In order to increase response rates glucocorticosteroid withdrawal therapy has been proposed as a pretrea... |
| Date: | May 2005 |
| Title: | Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Milk thistle (Silybum marianum (L) Gaertneri) extracts have been used as medical remedies since the time of ancient Greece. Alcohol and hepatotoxic viruses are the major causes of liver diseases. Several trials have studied the effects of milk thistle f... |
| Date: | Jan 2005 |
| Title: | Hepatitis B vaccination for patients with chronic renal failure |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Patients with chronic renal failure are at increased risk of hepatitis B virus infections. This review was undertaken to determine the beneficial and harmful effects of vaccination against hepatitis B and of a reinforced recombinant vaccination series. ... |
| Date: | May 2004 |
| Title: | Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | There is inadequate evidence to decide whether screening for liver cancer with alpha-fetoprotein and/or ultrasound of the liver compared to no screening is beneficial to patients infected with the hepatitis B virus. Only two randomised trials could be i... |
| Date: | Nov 2002 |
| Title: | Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infection |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Chinese medicinal herbs have a long history in the treatment of liver diseases. Three randomised clinical trials were included. Due to their poor methodologic quality and the existing small number of trials, there is currently insufficient evidence for ... |
| Date: | Feb 2001 |
| Title: | Chinese medicinal herbs for chronic hepatitis B |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Chronic hepatitis B is an infectious disease of the liver caused by hepatitis B virus. Around 350 million people worldwide are chronic infected carriers of the virus. Traditional Chinese medicinal herbs have for long been used for treating chronic liver... |
| Date: | Oct 2000 |
Results 1 to 13 displayed.
